Disclaimer: All information on this section is of a general nature.
Before making any investment decision, you should consult your adviser.
·
Maiden NPAT of A$3.2m versus a loss of A$19.1m
in the pcp.
·
Operating revenue +78% to A$35.7m from the pcp’s
A$20m.